Profiel
Mr. Marc Le Bozec is a Chief Executive Officer & Director at OSE Immunotherapeutics SA, a Treasurer & Director at France Biotech Association, a Chief Executive Officer at CYTOO SA and a Chairman at La Financière du Faouet SASU.
He is on the Board of Directors at OSE Immunotherapeutics SA, NH TherAguix SAS, France Biotech Association, Clevexel Pharma SAS, Keranova SA, Mexbrain SAS, Monatomics Technology SAS, NG Biotech SAS, Scipio Bioscience SAS and TransCure BioServices SASU.
Mr. Le Bozec was previously employed as a Fund Manager by Financière Arbevel SA, a Chief Financial Officer & IR Contact by Cellectis SA, and a Chairman & Chief Executive Officer by BioProtein Technologies SA. He also served on the board at Takara Bio Europe AB. He received his undergraduate degree from École des Hautes Études Commerciales de Paris.
Actieve functies van Marc Le Bozec
| Bedrijven | Functie | Begin |
|---|---|---|
| NH THERAGUIX SAS | Directeur/Bestuurslid | 22-02-2019 |
| OSE IMMUNOTHERAPEUTICS | Algemeen Directeur | 30-09-2025 |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Bestuurslid | - |
La Financière du Faouet SASU | Voorzitter | - |
Monatomics Technology SAS | Directeur/Bestuurslid | - |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic | Directeur/Bestuurslid | - |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Directeur/Bestuurslid | - |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology Develops and manufactures in vitro diagnostic tools | Directeur/Bestuurslid | - |
Transcure Bioservices SAS
Transcure Bioservices SAS Packaged SoftwareTechnology Services Develops humanized software platform | Directeur/Bestuurslid | 01-01-2019 |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Eerdere bekende functies van Marc Le Bozec
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Opleiding van Marc Le Bozec
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 17 |
|---|---|
Financière Arbevel SA
Financière Arbevel SA Investment ManagersFinance ARBEVEL is an active, long-term manager which focuses on the French small and mid-cap segment. The firm follows a pragmatic and opportunistic approach to investments in growth companies which they consider undervalued by the market or companies undergoing restructuring. They also seek to identify the companies best positioned to benefit from major structural trends including technological breakthroughs, biotechnology stakes, security, aging of the population, in order to accompany them in their development. ARBEVEL performs bottom-up, fundamental and strategic analysis of companies, including business analysis, the competitive environment, financial situation, management and valuation of the company. | Finance |
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Transcure Bioservices SAS
Transcure Bioservices SAS Packaged SoftwareTechnology Services Develops humanized software platform | Technology Services |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic | Health Technology |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology Develops and manufactures in vitro diagnostic tools | Health Technology |
NH TherAguix SAS
NH TherAguix SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in other physical and natural sciences | Commercial Services |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Health Technology |
Monatomics Technology SAS | |
La Financière du Faouet SASU |
















